28 results on '"Khashab, Tamer"'
Search Results
2. Data from HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
3. Supplementary figure from HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
4. Spontaneous regression of interdigitating dendritic sarcoma in a patient with concurrent small lymphocytic lymphoma
5. Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
6. Abstract 549: Genomic characterization and monitoring molecular response to treatment in African American (AA) advanced prostate cancer (PC) patients (pts) via next-generation sequencing (NGS): Real-world experience in a safety net hospital Oncology clinic
7. Genomic landscape of advanced prostate cancer in racial minority populations: Real-world experience in a safety-net hospital oncology clinic.
8. Prevalence of microsatellite instability and monitoring response to immune checkpoint inhibition utilizing liquid biopsy among African American men with advanced prostate cancer.
9. Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma
10. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma
11. Overcoming ibrutinib resistance by targeting phosphatidylinositol-3-kinase signaling in diffuse large B-cell lymphoma
12. Fibroblast Growth Factor-1 Inhibition Enhances FAS-Induced Apoptosis in Mantle Cell Lymphoma Cells By Accelerated BIRC2/3 Degradation
13. Purine Analogs for Patients with Non-Hodgkin Lymphoma and Severe Liver Dysfunction
14. MOESM5 of LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
15. THE SHOCKING TRUTH: PHANTOM SHOCKS AS A MANIFESTATION OF PSYCHOLOGICAL PROBLEMS ASSOCIATED WITH ICD INSERTION
16. Ten-year follow-up of pentostatin combined with cyclophosphamide, and rituximab in previously untreated indolent B-cell lymphoma.
17. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
18. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
19. Resolution of lung adenocarcinoma after discontinuation of ibrutinib
20. Abstract 306: Analysis of differentially expressed exosomal genes from ibrutinib resistant diffuse large B cell lymphoma
21. Abstract 3286: Targeting mir101/ EZH2/NFkb axis by FGFR1 inhibitor in mantle cell lymphoma
22. Tumor Microenvironment Regulates Survival of Mantle Cell Lymphoma Cells through Various Signaling Pathways
23. Abstract 445: Tumor microenvironment influences survival of mantle cell lymphoma-initiating cells through FGF/FGFR1 signaling
24. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
25. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
26. MOESM7 of LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
27. MOESM7 of LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
28. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.